1. |
Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol, 2005, 23(34): 8706-8712.
|
2. |
Partelli S, Fernandez-Del Castillo C, Bassi C, et al. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio. Ann Surg, 2010, 251(3): 477-482. .
|
3. |
Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol, 2009, 27(7): 1062-1068.
|
4. |
Kunisaki C, Makino H, Akiyama H, et al. Clinical significance of the metastatic lymphnode ratio in early gastric cancer. J Gastrointest Surg, 2008, 12(3): 542-549.
|
5. |
Sobin LH GM, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley. 2009.
|
6. |
Wei S, Asamura H, Kawachi R, et al. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol, 2011, 6(2): 310-318.
|
7. |
Wisnivesky JP, Arciniega J, Mhango G, et al. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax, 2011, 66(4): 287-293.
|
8. |
Matsuguma H, Oki I, Nakahara R, et al. Proposal of new nodal classifications for non-small cell lung cancer based on the number and ratio of metastatic lymph nodes. Eur J Cardiothorac Surg, 2012, 41(1): 19-24.
|
9. |
Wang CL, Li Y, Yue DS, et al. Value ofthe metastatic lymph node ratio for predicting the prognosis of non-small cell lung cancer patients. World J Surg, 2012, 36(2): 455-462.
|
10. |
Fukui T, Mori S, Yokoi K, et al. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol, 2006, 1(2): 120-125.
|
11. |
Lee JG, Lee CY, Park IK, et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg, 2008, 85(1): 211-215.
|
12. |
Lee CW, Wilkinson KH, Sheka AC, et al. The log odds of positive lymph nodes stratifies and predicts survival of high-risk individuals among stage Ⅲ rectal cancer patients. Oncologist, 2016, 21(4): 425-432.
|
13. |
Riediger H, Keck L, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg, 2009, 13(7): 1337-1344.
|
14. |
Inoue K, Nakane Y, liyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol, 2002, 9(1): 27-34.
|
15. |
Nwogu CE, Groman A, Fahey D, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg, 2012, 93(5): 1614-1619.
|
16. |
Bria E, Milella M, Sperduti I, et al. A novel clinical prognostic score incorporating the number of resected lymph nodes to predict recurrence and survival in non-small cell lung cancer. Lung Cancer, 2009, 66(3): 365-371.
|
17. |
Lee SH, Jo EJ, Eom JS, et al. Predictors of recurrence after curative resection in patients with early-stage non-small cell lung cancer. Tuberc Respir Dis (Seoul), 2015, 78(4): 341-348.
|
18. |
Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer, 2009, 115(22): 5218-5227.
|
19. |
Varlotto JM, Recht A, Flickinger JC, et al. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer, 2009, 115(5): 1059-1069.
|
20. |
Jonnalagadda S, Arcinega J, Smith C, et al. Validation of the lymph node ratio as a prognostic factor in patients with N1 non-small cell lung cancer. Cancer, 2011, 117(20): 4724-4731.
|